Mitochondrial toxicity

Mitochondrial Toxicity
Synonyms	N/A
Pronounce	N/A
Specialty	N/A
Symptoms	Fatigue, muscle weakness, lactic acidosis
Complications	Myopathy, Neuropathy, Lactic acidosis
Onset
Duration
Types	N/A
Causes	Drug-induced, Genetic disorders
Risks
Diagnosis	Biopsy, Blood tests, Genetic testing
Differential diagnosis	N/A
Prevention	N/A
Treatment	Discontinuation of offending drug, supportive care
Medication	N/A
Prognosis	Variable
Frequency
Deaths	N/A

Mitochondrial toxicity refers to the damage or dysfunction of mitochondria, the energy-producing organelles within cells, often as a result of exposure to certain drugs or toxins. This condition can lead to a variety of clinical manifestations, depending on the extent and location of the mitochondrial damage.

Pathophysiology

Mitochondria are responsible for producing adenosine triphosphate (ATP) through the process of oxidative phosphorylation. They also play a crucial role in apoptosis, calcium homeostasis, and the generation of reactive oxygen species (ROS). Mitochondrial toxicity occurs when these functions are impaired, leading to decreased ATP production, increased oxidative stress, and potential cell death.

Mechanisms of Toxicity

Mitochondrial toxicity can occur through several mechanisms:

• Inhibition of the Electron Transport Chain (ETC): Certain drugs can inhibit complexes I-IV of the ETC, reducing ATP production and increasing ROS.
• Disruption of Mitochondrial DNA (mtDNA): Some agents can cause mutations or deletions in mtDNA, impairing mitochondrial function.
• Impairment of Fatty Acid Oxidation: This can lead to the accumulation of toxic lipid intermediates.
• Induction of Apoptosis: Mitochondrial dysfunction can trigger apoptotic pathways, leading to cell death.

Causes

Mitochondrial toxicity can be caused by a variety of factors, including:

Drug-Induced

Several classes of drugs are known to cause mitochondrial toxicity:

• Antiretroviral drugs: Particularly nucleoside reverse transcriptase inhibitors (NRTIs) such as zidovudine and stavudine.
• Antibiotics: Some aminoglycosides and linezolid.
• Chemotherapeutic agents: Such as doxorubicin and cisplatin.
• Antipsychotics and Antidepressants: Certain drugs in these classes can affect mitochondrial function.

Genetic Disorders

Inherited mitochondrial diseases, such as Leigh syndrome and Mitochondrial myopathy, can also lead to mitochondrial dysfunction.

Clinical Manifestations

The symptoms of mitochondrial toxicity can vary widely but often include:

• Fatigue and Muscle weakness: Due to decreased ATP production.
• Lactic acidosis: Resulting from impaired oxidative phosphorylation.
• Neuropathy and Myopathy: Due to muscle and nerve cell damage.
• Hepatotoxicity: Liver dysfunction can occur in severe cases.

Diagnosis

Diagnosing mitochondrial toxicity involves a combination of clinical evaluation and laboratory tests:

• Blood tests: To check for elevated lactate levels and liver enzymes.
• Muscle biopsy: Can reveal ragged red fibers and other mitochondrial abnormalities.
• Genetic testing: To identify mutations in mtDNA or nuclear DNA affecting mitochondrial function.

Management

The primary approach to managing mitochondrial toxicity is to discontinue the offending drug if possible. Additional supportive measures include:

• Nutritional support: Supplementation with coenzyme Q10, L-carnitine, and other antioxidants.
• Symptomatic treatment: Addressing specific symptoms such as neuropathy or myopathy.

Prognosis

The prognosis of mitochondrial toxicity depends on the extent of mitochondrial damage and the ability to remove the causative agent. Early detection and intervention can improve outcomes.

Prevention

Preventive strategies include:

• Monitoring drug levels: Especially in patients on long-term therapy with known mitochondrial toxicants.
• Genetic counseling: For individuals with a family history of mitochondrial disorders.

See Also

• Mitochondrial disease
• Oxidative stress
• Drug toxicity